FRMO Corp. Completes Restatement of Previously Issued Financial Statements
FRMO is trading near its 52-week low of $7.03 (15% above the low).
Summary
FRMO Corp. has announced the completion of its restatement of previously issued financial statements for fiscal years 2024 and 2025, along with associated interim periods. This action resolves a significant compliance issue, bringing the company back into full compliance with OTC Markets Group's reporting requirements. Importantly, the restatements, which corrected the valuation of deferred tax liabilities and income tax provisions, did not impact the company's cash and cash equivalents, total assets, net income or loss from operations before income taxes, or cash flows from operations. This removes an overhang of uncertainty regarding the company's financial reporting integrity and compliance status.
At the time of this announcement, FRMO was trading at $8.05 on OTC in the Finance sector, with a market capitalization of approximately $354.4M. The 52-week trading range was $7.03 to $9.69. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Acceswire.